GYS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.439200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.111800E-01
Normal-vs-Stage2
5.849200E-01
Normal-vs-Stage3
9.138600E-01
Normal-vs-Stage4
4.924400E-01
Stage1-vs-Stage2
3.802600E-01
Stage1-vs-Stage3
9.439000E-01
Stage1-vs-Stage4
4.452200E-01
Stage2-vs-Stage3
4.284800E-01
Stage2-vs-Stage4
8.582600E-01
Stage3-vs-Stage4
6.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.469600E-01
Normal-vs-AfricanAmerican
9.110000E-01
Normal-vs-Asian
3.917800E-01
Caucasian-vs-AfricanAmerican
4.113600E-01
Caucasian-vs-Asian
2.113000E-01
AfricanAmerican-vs-Asian
2.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.896600E-01
Normal-vs-Female
6.000800E-01
Male-vs-Female
5.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.226600E-01
Normal-vs-Age(41-60Yrs)
4.760400E-01
Normal-vs-Age(61-80Yrs)
7.527200E-01
Normal-vs-Age(81-100Yrs)
5.178400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.32920000004167E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.390600E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.724300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.122000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.927200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.303400E-01
Normal-vs-Daily Drinker
4.499600E-01
Normal-vs-Weekly Drinker
2.972400E-01
Normal-vs-Occasional Drinker
3.904000E-01
Normal-vs-Social Drinker
6.313000E-01
Non Drinker-vs-Daily Drinker
2.533400E-01
Non Drinker-vs-Weekly Drinker
2.010400E-01
Non Drinker-vs-Occasional Drinker
1.396990E-01
Non Drinker-vs-Social Drinker
6.556400E-01
Daily Drinker-vs-Weekly Drinker
7.260800E-01
Daily Drinker-vs-Occasional Drinker
5.919600E-01
Daily Drinker-vs-Social Drinker
4.774800E-01
Weekly Drinker-vs-Occasional Drinker
8.472000E-01
Weekly Drinker-vs-Social Drinker
2.864000E-01
Occasional Drinker-vs-Social Drinker
2.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.114200E-01
Normal-vs-Grade 2
7.434600E-01
Normal-vs-Grade 3
3.404000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.876000E-02
Grade 1-vs-Grade 3
5.131600E-02
Grade 1-vs-Grade 4
7.114200E-01
Grade 2-vs-Grade 3
5.323600E-01
Grade 2-vs-Grade 4
7.434600E-01
Grade 3-vs-Grade 4
3.404000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.262400E-01
Normal-vs-NonDiabetic
5.155800E-01
Diabetic-vs-NonDiabetic
1.259020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.016420E-01
Normal-vs-NoPancreatitis
6.664400E-01
Pancreatitis-vs-NoPancreatitis
6.667900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.951200E-01
Normal-vs-N1
6.166800E-01
N0-vs-N1
4.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.179800E-01
Normal-vs-TP53-NonMutant
6.648600E-01
TP53-Mutant-vs-TP53-NonMutant
9.83840000023939E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
